MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features

被引：0
|
作者：
Yuan, Lisi [1 ]
Bosler, David [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Cleveland Clin, Beachwood, OH USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1974
引用
收藏
页码：1831 / 1832
页数：2
相关论文
共 50 条
  • [1] MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
    Yuan, Lisi
    Mehrotra, Harshita
    He, Xin
    Bosler, David
    JOURNAL OF MOLECULAR PATHOLOGY, 2023, 4 (01): : 46 - 56
  • [2] MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
    Yuan, Lisi
    Bosler, David
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1831 - 1832
  • [3] Cytomorphology of Non-Small Cell Lung Carcinoma with MET Exon 14 Skipping Mutations
    Labiano, Tania
    Echegoyen, Ana
    Moneo, Marta
    Elizalde, Jesus
    Guerrero, David
    LABORATORY INVESTIGATION, 2024, 104 (03) : S438 - S439
  • [4] Clinicopathologic Characteristics of Non-Small Cell Lung Carcinomas Harboring MET Exon 14 Skipping Mutations
    Fujii, T.
    Uruga, H.
    Nakamura, N.
    Kohno, T.
    Kishi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2254 - S2255
  • [5] MET Exon 14 Skipping in Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    Shim, Hyo Sup
    Gingipally, Shalini
    Mino-Kenudson, Mari
    Le, Long
    Gainor, Justin F.
    Zheng, Zongli
    Aryee, Martin
    Xia, Junfeng
    Jia, Peilin
    Jin, Hailing
    Zhao, Zhongming
    Pao, Gwilliam
    Engelman, Jeffrey A.
    Iafrate, A. John
    ONCOLOGIST, 2016, 21 (04): : 481 - 486
  • [6] Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Zhang, Eric W.
    Lennerz, Jochen K.
    Heist, Rebecca S.
    CANCERS, 2019, 11 (12)
  • [7] Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer with MET Exon 14 Skipping
    Han, Y.
    Chen, S.
    Xiang, C.
    Guo, L.
    Zhu, L.
    Shao, J.
    Hu, T.
    Wang, J.
    Zhu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S60 - S61
  • [8] Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients
    Prince, S. Savic
    Bihl, M.
    Eppenberger-Castori, S.
    Matter, M. S.
    Zellweger, N.
    Rothschild, S. I.
    Bubendorf, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S700 - S700
  • [9] MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer
    Zheng, Difan
    Wang, Rui
    Ye, Ting
    Yu, Su
    Hu, Haichuan
    Shen, Xuxia
    Li, Yuan
    Ji, Hongbin
    Sun, Yihua
    Chen, Haiquan
    ONCOTARGET, 2016, 7 (27) : 41691 - 41702
  • [10] The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping
    Salgia, Ravi
    Sattler, Martin
    Scheele, Juergen
    Stroh, Christopher
    Felip, Enriqueta
    CANCER TREATMENT REVIEWS, 2020, 87
12345